Medical Device News Magazine

IAI Announces Medical Assist ELECYLINDER Series

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

 

April 1, 2021

IAI (Intelligent Actuator Incorporated) would like to introduce their ELECYLINDER® electric actuator series.

The main features are easy operation, AVD (acceleration/speed/deceleration) that can be adjusted individually, and high performance. Due to its stable quality, it is ideal for the manufacturing industry of medical products where product accuracy is required.

Here is an example of how the smooth operation of ELECYLINDER® improved a packaging application. Previously, an air cylinder was used to transfer accepted products. To achieve a shorter cycle time, the air cylinder was operated at a high speed but gave a big shock at the time of the stoppage. As a result, some temporary stops took place in the post-process due to the dispersion of transferred positions of accepted products. Since the ELECYLINDER can adjust acceleration/deceleration, there is no shock even at a high-speed operation. As a result, the dispersion of the transferred positions was eliminated, reducing temporary stops and shortening the cycle time.

ELECYLINDER® makes it easy to adjust and control AVD (A: Acceleration, V: Speed, D: Deceleration), allowing packages to move smoothly between conveyors positioned at right angles without affecting internal products. In addition, ELECYLINDER® has a wide range of products available for many types of applications.

“IAI is proud to be at the forefront of technology that supports the medical community in the fight against disease and future health crises,” said Kaz Haruna, National Sales Manager at IAI America.

IAI is actively assisting the medical community by providing Cartesian and SCARA robots for infectious disease testing, molecular diagnostics, tissue and blood sampling, genomic research, cancer research, pharmaceuticals, and medical device production. It is IAI’s hope that our ELECYLINDER® Series will help the medical/pharmaceutical industries move ahead with advanced innovation.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”